Lapointe HR, Mwimanzi F, Cheung PK, Sang Y, et al. People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses. J Infect Dis 2022 Jun 7. pii: 6603521. doi: 10.1093.
PMID: 35668700